The Searle Company Limited (PSX:SEARL)
84.86
-1.71 (-1.98%)
At close: Mar 6, 2026
The Searle Company Revenue
The Searle Company had revenue of 9.96B PKR in the quarter ending December 31, 2025, with 35.09% growth. This brings the company's revenue in the last twelve months to 33.26B, up 15.47% year-over-year. In the fiscal year ending June 30, 2025, The Searle Company had annual revenue of 28.60B, down -2.72%.
Revenue (ttm)
33.26B
Revenue Growth
+15.47%
P/S Ratio
1.50
Revenue / Employee
8.75M
Employees
3,799
Market Cap
49.92B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 28.60B | -800.84M | -2.72% |
| Jun 30, 2024 | 29.40B | 3.60B | 13.97% |
| Jun 30, 2023 | 25.80B | -4.11B | -13.75% |
| Jun 30, 2022 | 29.91B | 3.69B | 14.07% |
| Jun 30, 2021 | 26.22B | 5.74B | 28.06% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Abbott Laboratories (Pakistan) | 74.84B |
| GlaxoSmithKline Pakistan | 62.07B |
| AGP Limited | 27.73B |
| Highnoon Laboratories | 26.61B |
| Ferozsons Laboratories | 22.22B |
| Citi Pharma | 14.10B |
| Macter International | 11.58B |
| Otsuka Pakistan | 4.26B |